Table 2.
Comparison of mean MVI and PH change in the licorice and placebo groups before and 8 weeks after the treatment.
| Licorice |
Placebo |
p-value* | |
|---|---|---|---|
| (n = 35) |
(n = 35) |
||
| n (%) | n (%) | ||
| MVI | |||
| Before therapy | |||
| 0-49 | 35 (100) | 35 (100) | 0.31 |
| 50-64 | 0 (0%) | 0 (0%) | |
| 65-100 | 0 (0%) | 0 (0%) | |
| MVI, M (SD) | 17.70 (10.03) | 20.11 (9.88) | |
| 8 weeks after therapy | |||
| 0-49 | 2 (5.7) | 21 (0.60) | 0.001 |
| 50-64 | 2 (5.7) | 10 (28.6) | |
| 65-100 | 29 (82.9) | 4 (11.4) | |
| MVI, M (SD) | 85.18 (15.75) | 45.77 (21.39) | |
| P-value** | 0.001 | 0.001 | |
| pH | |||
| Before therapy | |||
| <5 | 0 (0%) | 0 (0%) | 0.38 |
| 5–5.49 | 6 (17.1) | 5 (14.3) | |
| 5.5–6.49 | 19 (54.3) | 16 (45.7) | |
| <6.49 | 10 (28.6) | 14 (40.0) | |
| 8 weeks after therapy | |||
| <5 | 31 (88.6) | 5 (14.3) | 0.001 |
| 5–5.49 | 2 (5.7) | 8 (22.9) | |
| 5.5–6.49 | 0 (0) | 13 (37.1) | |
| <6.49 | 0 (0) | 9 (25.7) | |
| P-value** | 0.001 | 0.001 | |
* Between the groups.
** Within the groups.